Asthma Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Asthma stocks.

Recent Signals

Date Stock Signal Type
2021-04-09 ATR Bollinger Band Squeeze Range Contraction
2021-04-09 ATR Three Weeks Tight Range Contraction
2021-04-09 AZN Crossed Above 20 DMA Bullish
2021-04-09 AZN Crossed Above 50 DMA Bullish
2021-04-09 AZN Bollinger Band Squeeze Range Contraction
2021-04-09 CNTB Hot IPO Pullback Bullish Swing Setup
2021-04-09 CNTB NR7 Range Contraction
2021-04-09 DVAX 20 DMA Support Bullish
2021-04-09 DVAX Bollinger Band Squeeze Range Contraction
2021-04-09 GSK 180 Bullish Setup Bullish Swing Setup
2021-04-09 GSK MACD Bullish Signal Line Cross Bullish
2021-04-09 GSK Bollinger Band Squeeze Range Contraction
2021-04-09 HZNP Narrow Range Bar Range Contraction
2021-04-09 IDRA 1,2,3 Retracement Bearish Bearish Swing Setup
2021-04-09 IDRA MACD Bullish Signal Line Cross Bullish
2021-04-09 IDRA Narrow Range Bar Range Contraction
2021-04-09 IDRA Boomer Sell Setup Bearish Swing Setup
2021-04-09 IDRA Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-09 INFI 20 DMA Support Bullish
2021-04-09 INFI Narrow Range Bar Range Contraction
2021-04-09 INFI Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2021-04-09 INFI Fell Below 50 DMA Bearish
2021-04-09 INVA MACD Bearish Signal Line Cross Bearish
2021-04-09 INVA 50 DMA Resistance Bearish
2021-04-09 INVA 200 DMA Resistance Bearish
2021-04-09 PIRS MACD Bullish Centerline Cross Bullish
2021-04-09 PIRS 200 DMA Support Bullish
2021-04-09 PIRS 50 DMA Support Bullish
2021-04-09 REGN 50 DMA Resistance Bearish
2021-04-09 REGN Bollinger Band Squeeze Range Contraction
2021-04-09 REGN 20 DMA Resistance Bearish
2021-04-09 RIGL New Downtrend Bearish
2021-04-09 RIGL Narrow Range Bar Range Contraction
2021-04-09 RIGL NR7-2 Range Contraction
2021-04-09 RIGL NR7 Range Contraction
2021-04-09 TEVA Bollinger Band Squeeze Range Contraction
2021-04-09 TEVA NR7 Range Contraction
2021-04-09 TMO Upper Bollinger Band Walk Strength
2021-04-09 VRNA Fell Below 50 DMA Bearish
2021-04-09 VRNA Stochastic Sell Signal Bearish
2021-04-09 XNCR Stochastic Reached Oversold Weakness
2021-04-09 XNCR Fell Below 200 DMA Bearish

Recent News for Asthma Stocks

Date Stock Title
Apr 12 GSK Zentalis's Early WEE1 Inhibitor Data Shows 'Exceptional' Response In Solid Tumor Study, Plans Combination Trials
Apr 12 REGN Taking A Breather for Now
Apr 12 AZN UPDATE 1-Brazil, Mexico, Philippines among those due to get Pfizer shots from COVAX in Q2 - statement
Apr 12 REGN Regeneron’s Covid-19 Antibody Protects Household Contacts From Infection
Apr 12 REGN Regeneron’s REGEN-COV Shown To Reduce COVID-19 Progression In Phase 3 Trial
Apr 12 HZNP Horizon Therapeutics plc Named One of the Fortune 100 Best Companies to Work For®
Apr 12 TMO FDA Authorizes New High-Throughput, Automated System for Leading COVID-19 Test
Apr 12 REGN Regeneron says its COVID-19 antibody therapy cut risk of infection progression
Apr 12 REGN Wall Street Breakfast: Alibaba Relief
Apr 12 AZN J&J's (JNJ) COVID-19 Jab Under EU Review for Rare Blood Clots
Apr 12 ADMP Adamis Pharmaceuticals Provides an Update on ZIMHI™
Apr 12 AZN AstraZeneca’s oral COVID-19 therapy fails in late-stage trial
Apr 12 REGN UPDATE 1-Regeneron's COVID-19 cocktail helps prevent symptomatic disease - study
Apr 12 AZN AstraZeneca Farxiga Drug Doesn't Work Against COVID-19
Apr 12 REGN Regeneron/Roche's antibody cocktail reduces risk of COVID-19 infections
Apr 12 AZN UPDATE 2-AstraZeneca's diabetes drug Farxiga fails in COVID-19 study
Apr 12 REGN Phase 3 Treatment Trial in Recently Infected Asymptomatic Patients Showed REGEN-COV™ (casirivimab with imdevimab) Significantly Reduced Progression to Symptomatic COVID-19
Apr 12 REGN Phase 3 Prevention Trial Showed 81% Reduced Risk of Symptomatic SARS-CoV-2 Infections with Subcutaneous Administration of REGEN-COV™ (casirivimab with imdevimab)
Apr 12 AZN Collateral trade benefit of Biden’s tax reform
Apr 12 REGN Regeneron’s Covid drug reduces risk of symptomatic illness, study finds

Asthma is a common long-term inflammatory disease of the airways of the lungs. It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath. These episodes may occur a few times a day or a few times per week. Depending on the person, they may become worse at night or with exercise.Asthma is thought to be caused by a combination of genetic and environmental factors. Environmental factors include exposure to air pollution and allergens. Other potential triggers include medications such as aspirin and beta blockers. Diagnosis is usually based on the pattern of symptoms, response to therapy over time, and spirometry. Asthma is classified according to the frequency of symptoms, forced expiratory volume in one second (FEV1), and peak expiratory flow rate. It may also be classified as atopic or non-atopic, where atopy refers to a predisposition toward developing a type 1 hypersensitivity reaction.There is no cure for asthma. Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by the use of inhaled corticosteroids. Long-acting beta agonists (LABA) or antileukotriene agents may be used in addition to inhaled corticosteroids if asthma symptoms remain uncontrolled. Treatment of rapidly worsening symptoms is usually with an inhaled short-acting beta-2 agonist such as salbutamol and corticosteroids taken by mouth. In very severe cases, intravenous corticosteroids, magnesium sulfate, and hospitalization may be required.In 2015, 358 million people globally had asthma, up from 183 million in 1990. It caused about 397,100 deaths in 2015, most of which occurred in the developing world. It often begins in childhood. The rates of asthma have increased significantly since the 1960s. Asthma was recognized as early as Ancient Egypt. The word "asthma" is from the Greek ἅσθμα, ásthma, which means "panting".

More about Asthma
Browse All Tags